compound-52

NG 52 (NG-52) is a cell-permeable, reversible, and ATP-compatible inhibitor of the cell cycle-regulating kinase Cdc28p and the related Pho85p kinase.

Compound 58933-52-1, with CAS No. 58933-52-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 58933-52-1 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

BRK inhibitor P21d hydrochloride is a highly potent inhibitor of breast tumor kinase (BRK/PTK6), displaying an IC50 of 30 nM, and effectively suppresses p-SAM68 with an IC50 of 52 nM. This compound serves as a valuable tool for evaluating BRK inhibitors' efficacy in xenograft breast tumor models, enabling in vivo activity assessment.

Compound FL0044, with CAS No. 345965-52-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0044 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12558, with CAS No. 72752-52-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12558 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13781, with CAS No. 16263-52-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13781 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13840, with CAS No. 55557-52-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13840 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13958, with CAS No. 2524-52-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13958 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14039, with CAS No. 177492-52-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14039 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14072, with CAS No. 3034-52-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14072 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0079, with CAS No. 15128-52-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0079 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0135, with CAS No. 253-52-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0135 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0217, with CAS No. 42142-52-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0217 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0367, with CAS No. 827-52-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0367 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0390, with CAS No. 90-52-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0390 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Dibutyl carbonate is a useful organic compound for research related to life sciences. The catalog number is T2152 and the CAS number is 542-52-9.

Beauveriolide III, a cyclodepsipeptide found in Beauveria fungi, inhibits lipid droplet formation (at 3-10 μM) and cholesterol synthesis (IC50=0.41 μM). This compound also suppresses acyl-coenzyme A:cholesterol acyltransferase (ACAT) activity (IC50=5.5 μM) and reduces atherosclerotic lesion size in Ldlr-/- and ApoE-/- mouse models (25-50 mg/kg).

Compound Fr12159, with CAS No. 6149-52-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12159 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12325, with CAS No. 251649-52-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12325 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12479, with CAS No. 187533-52-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12479 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13126, with CAS No. 16234-52-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13126 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13214, with CAS No. 518995-52-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13214 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13997, with CAS No. 519056-52-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13997 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr16618, with CAS No. 886851-52-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr16618 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.